Endometrioid Stromal Sarcoma — Clinical Trials

MONDO:00067453 active·2 recruitingLast updated: Mar 19, 2026, 2:33 AM

Trial Landscape

Endometrioid Stromal Sarcoma has an emerging clinical trial program, driven by drug treatment and biological therapy.

Recruiting

Active Trials

By Approach

Drug Treatment3

Biological Therapy1

By Phase

Phase 2

Sponsor Types

Academic/Other2Industry1

Top Sponsors

HRYZ Biotech Co.

Trial Locations

United States1 trial

China1 trial

France1 trial

Trials often recruit across multiple countries, so totals exceed the trial count.

3 Trials

Phase 2Recruiting

NCT03624244

Evaluation of Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic Low Grade Endometrial Stromal Sarcoma (LGESS)

Sponsor:Centre Leon Berard

FranceStarted: Jan 2019Est. completion: Jan 2031Updated: Feb 2026

Phase 2Recruiting

NCT06277154

MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma

Sponsor:HRYZ Biotech Co.

ChinaStarted: Feb 2024Est. completion: Feb 2027Updated: Jul 2025

Phase 2Not Yet Recruiting

NCT07467772

Ph 2 Elacestrant in ER Positive Uterine Sarcomas

Sponsor:Dana-Farber Cancer Institute

United StatesStarted: Feb 2026Est. completion: Apr 2028Updated: Mar 2026

Stay informed about clinical trials for Endometrioid Stromal Sarcoma.

Follow this disease to get updates when trials open, close, or change status.

Follow This Disease — Free

Already have an account? Sign in to manage your watchlists.

Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.

Last sync: March 19, 2026 at 2:33 AM